PeerView | Gynaecology/Obstetrics

Free CME from PeerView

Gynecology/Obstetrics CME

Medical Learning Institute, Inc.

The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes

Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD

April 05, 2021

Medical Learning Institute, Inc.

Rewriting the Rules for Early Cancer Screening: Case-Based Insight on Primary Care Principles for Using Blood-Based Screening Techniques

John J. Russell, MD

March 25, 2021

Medical Learning Institute, Inc.

Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses

Minetta C. Liu, MD

March 18, 2021

Medical Learning Institute, Inc.

MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies

Maria K. Houtchens, MD, MMs

January 22, 2021

Medical Learning Institute, Inc.

Realizing the Potential of CDK 4/6 Inhibitor Therapy in Breast Cancer: An Examination of the Evidence That Is Informing Real-World Practice

Adam Brufsky, MD, PhD

September 30, 2020

Medical Learning Institute, Inc.

The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage and Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons

George Plitas, MD

August 28, 2020

Medical Learning Institute, Inc.

Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations

Erika Hamilton, MD

August 06, 2020

Medical Learning Institute, Inc.

Rethinking Patient Care in Endometrial and Cervical Cancer: How Nurses Can Lead the Targeted and Immunotherapeutic Revolution

Kimberly Halla, MSN, FNP-C

August 05, 2020

Medical Learning Institute, Inc.

Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What Do You Need to Know?

Georgine Lamvu, MD, MPH

August 03, 2020

Medical Learning Institute, Inc.

Evidence Informing Practice: Changing Standards of Care for Use of CDK4 and 6 Inhibitors in the Treatment of Breast Cancer

Joyce O’Shaughnessy, MD

July 23, 2020

Medical Learning Institute, Inc.

Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics

Bradley J. Monk, MD, FACS, FACOG

July 21, 2020

Medical Learning Institute, Inc.

Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer Management: Exploring Innovative Therapy in Gynecologic Malignancies

Linda R. Duska, MD, MPH

July 17, 2020

Medical Learning Institute, Inc.

Chair's Take on Harnessing the Immune System in the Treatment of TNBC and Beyond: Where Are We Now and Where Are We Going Next?

Heather L. McArthur, MD, MPH

July 09, 2020

Pages